5/3/22 17:49 | 4/29/22 | TPST | Tempest Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Woiwode Thomas | CA | DT | | P | 5,000 | 2.36 | 0 | 2,119 | 97 | 4,295 | I | | | | | | | | | | | | | | |
1/4/21 18:02 | 12/30/20 | GRTS | Gritstone Oncology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | CA | D | | P | 5,000 | 3.71 | 0 | 1,348 | 43 | 4,451 | I | | | | | | | | | | | | | | |
10/20/20 17:00 | 10/20/20 | ALGS | Aligos Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | CA | D | | P.d | 3,000 | 15.00 | 0 | 200 | 30 | 862 | I | | | | | | | | | | | | | | |
3/3/20 18:57 | 3/3/20 | PASG | Passage Bio, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | CA | DT | | P.d | 4,050 | 18.00 | 0 | 225 | 5 | 4,960 | I | | | | | | | | | | | | | | |
5/17/18 17:11 | 5/15/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | MA | D | | S | -2,551 | 57.99 | 0 | -44 | -6 | 646 | I | | | | | | | | | | | | | | |
5/9/18 17:15 | 5/7/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | MA | D | | S.m | -6,116 | 50.39 | 0 | -121 | -56 | 96 | M | | | | | | | | | | | | | | |
5/2/18 18:00 | 4/30/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | MA | D | | S | -1,537 | 50.29 | 0 | -31 | -22 | 106 | I | | | | | | | | | | | | | | |
4/30/18 20:57 | 4/26/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | MA | D | | S.m | -11,136 | 50.11 | 0 | -222 | -69 | 101 | I | | | | | | | | | | | | | | |
4/26/18 17:01 | 4/24/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | MA | D | | S | -1,165 | 50.99 | 0 | -23 | -16 | 116 | I | | | | | | | | | | | | | | |
4/24/18 19:42 | 4/23/18 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | MA | D | | S | -5,169 | 50.68 | 0 | -102 | -45 | 124 | M | | | | | | | | | | | | | | |
12/27/17 16:14 | 12/22/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | MA | D | | S | -62 | 20.29 | 0 | -3 | -38 | 5 | D | | | | | | | | | | | | | | |
11/28/17 16:11 | 11/24/17 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | MA | D | | S.m | -38 | 20.21 | 0 | -2 | -19 | 8 | D | | | | | | | | | | | | | | |
12/23/16 18:03 | 10/24/16 | CRSP | Crispr Therapeutics AG | V8 | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | MA | D | | P.d | 2,254 | 14.00 | 1 | 161 | 27 | 763 | I | | | | | 19 | 6 | 3 | -2 | 1 | -3 | -10 | -13 | | |
7/25/16 17:09 | 7/25/16 | BOLD | Audentes Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Woiwode Thomas | CA | D | | P.d | 525 | 15.00 | 18 | 35 | 2 | 1,807 | I | | | | | | | | | 1 | -1 | 0 | 17 | -1 | |